pentetic acid has been researched along with hydralazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Belfi, CA; Ngo, FQ; Paul, CR; Shan, S | 1 |
| Lao, X; Nalcioglu, O; Roth, GM; Samoszuk, MK; Su, MY; Wang, Z | 1 |
1 review(s) available for pentetic acid and hydralazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for pentetic acid and hydralazine
| Article | Year |
|---|---|
Comparison of the effects of hydralazine on tumor and normal tissue blood perfusion by MRI.
Topics: Animals; Dose-Response Relationship, Drug; Gadolinium DTPA; Hydralazine; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Muscles; Organometallic Compounds; Pentetic Acid; Regional Blood Flow; Sarcoma, Experimental | 1994 |
Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI.
Topics: Adenocarcinoma; Angiotensin II; Animals; Blood Flow Velocity; Capillary Permeability; Cell Transplantation; Contrast Media; Female; Gadolinium DTPA; Hydralazine; Kidney; Liver; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Muscle, Skeletal; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Vasoconstrictor Agents; Vasodilator Agents | 1996 |